RNF20 promotes the polyubiquitination and proteasome-dependent degradation of AP-2α protein

Acta Biochimica et Biophysica Sinica

Volumn 46, Issue 2, 2014, Pages 136-140

  Ren, Peng ^a   Sheng, Zhifeng ^b   Wang, Yijun ^a,c   Yi, Xin ^a   Zhou, Qiuzhi ^a   Zhou, Jianlin ^a   Xiang, Shuanglin ^a   Hu, Xiang ^a   Zhang, Jian ^a  

^a HUNAN NORMAL UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c CHANGSHA MEDICAL UNIVERSITY   (China)

Author keywords

AP 2 ; C EBP ; E3 ubiquitin ligase; RNF20; ubiquitin proteasome dependent degradation

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; PROTEASOME; RNF20 PROTEIN, MOUSE; TRANSCRIPTION FACTOR AP 2; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E3;

3T3 CELL LINE; ADIPOCYTE; ADIPOGENESIS; ANIMAL; AP-2Α; ARTICLE; BIOSYNTHESIS; C/EBPΑ; CELL DIFFERENTIATION; GENETICS; METABOLISM; MOUSE; RNF20; UBIQUITIN-PROTEASOME-DEPENDENT DEGRADATION; UBIQUITINATION;

AP-2Α; C/EBPΑ; E3 UBIQUITIN LIGASE; RNF20; UBIQUITIN-PROTEASOME-DEPENDENT DEGRADATION;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL DIFFERENTIATION; MICE; PROTEASOME ENDOPEPTIDASE COMPLEX; TRANSCRIPTION FACTOR AP-2; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84893312061     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmt136     Document Type: Article

References (21)

1. Eckert D, Buhl S, Weber S, Jager R and Schorle H. The AP-2 family of transcription factors. Genome Biol 2005, 6: 246.
2. Pellikainen JM and Kosma VM. Activator protein-2 in carcinogenesis with a special reference to breast cancer-A mini review. Inter J Cancer 2007, 120: 2061-2067.
3. Jiang MS, Tang QQ, McLenithan J, Geiman D, Shillinglaw W, Henzel WJ and Lane MD. Derepression of the C/EBPalpha gene during adipogenesis: Identification of AP-2alpha as a repressor. Proc Natl Acad Sci USA 1998, 95: 3467-3471.
4. Holt EH and Lane MD. Downregulation of repressive CUP/AP-2 isoforms during adipocyte differentiation. Biochem Biophys Res Commun 2001, 288: 752-756.
5. Wu Z, Rosen ED, Brun R, Hauser S, Adelmant G, Troy AE and McKeon C, et al. Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell 1999, 3: 151-158.
6. Kerschgens J, Renaud S, Schutz F, Grasso L, Egener-Kuhn T, Delaloye JF and Lehr HA, et al. Protein-binding microarray analysis of tumor suppressor AP2alpha target gene specificity. PLoS ONE 2011, 6: E22895.
7. Garcia MA, Campillos M, Marina A, Valdivieso F and Vazquez J. Transcription factor AP-2 activity is modulated by protein kinase A-mediated phosphorylation. FEBS Lett 1999, 444: 27-31.
8. Ren K, Xian S, He F, Zhang W, Ding X, Wu Y and Yang L, et al. CK2 phosphorylates AP-2alpha and increases its transcriptional activity. BMB Rep 2011, 44: 490-495.
9. Ding X, Luo C, Zhou J, Zhong Y, Hu X, Zhou F and Ren K, et al. The interaction of KCTD1 with transcription factor AP-2alpha inhibits its transactivation. J Cell Biochem 2009, 106: 285-295.
10. Steffan JS, Agrawal N, Pallos J, Rockabrand E, Trotman LC, Slepko N and Illes K, et al. SUMO modification of Huntingtin and Huntingtons disease pathology. Science 2004, 304: 100-104.
11. Zhou Q, Wang Y, Liu Q, Li L, Zhang Hg, Zhou J and Ding X, et al. Separation and identification of AP-2a interacting proteins from mice pre-adipocyte cells. Acta Laser Biol Sin 2011, 20: 199-202.
12. Tansey WP. Detection of ubiquitylated proteins in mammalian cells. Cold Spring Harb Protoc 2006, http://cshprotocols.cshlp.org/content/2006/6/pdb. prot4616.abstract.
13. Zhu B, Zheng Y, Pham AD,Mandal SS, Erdjument-Bromage H, Tempst P and Reinberg D. Monoubiquitination of human histone H2B: The factors involved and their roles in HOX gene regulation. Mol Cell 2005, 20: 601-611.
14. Liu Z, Oh SM, Okada M, Liu X, Cheng D, Peng J and Brat DJ, et al. Human BRE1 is an E3 ubiquitin ligase for Ebp1 tumor suppressor. Mol Biol Cell 2009, 20: 757-768.
15. Imagawa M, Chiu R and Karin M. Transcription factor AP-2 mediates induction by two different signal-transduction pathways: Protein kinase C and cAMP. Cell 1987, 51: 251-260.
16. Budhidarmo R, Nakatani Y and Day CL. RINGs hold the key to ubiquitin transfer. Trends Biochem Sci 2012, 37: 58-65.
17. Hwang WW, Venkatasubrahmanyam S, Ianculescu AG, Tong A, Boone C and Madhani HD. A conserved RING finger protein required for histone H2B monoubiquitination and cell size control. Mol Cell 2003, 11: 261-266.
18. Shema E, Tirosh I, Aylon Y, Huang J, Ye C, Moskovits N and Raver-Shapira N, et al. The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression. Genes Dev 2008, 22: 2664-2676.
19. Arora M, Zhang J, Heine GF, Ozer G, Liu HW, Huang K and Parvin JD. Promoters active in interphase are bookmarked during mitosis by ubiquitination. Nucleic Acids Res 2012, 40: 10187-10202.
20. Shema E, Kim J, Roeder RG and Oren M. RNF20 inhibits TFIIS-facilitated transcriptional elongation to suppress pro-oncogenic gene expression. Mol Cell 2011, 42: 477-488.
21. Wang E, Kawaoka S, Yu M, Shi J, Ni T, Yang Wand Zhu J, et al. Histone H2B ubiquitin ligase RNF20 is required for MLL-rearranged leukemia. Proc Natl Acad Sci USA 2013, 110: 3901-3906.